Public Company News

Alphamab Oncology Presented Multiple Clinical Data of Anti-HER2 Biparatopic ADC JSKN003 at the 2025 ASCO Annual Meeting

SUZHOU, China, June 3, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that multiple clinical data updates for anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 were presented as posters at the 2025 Annual Meeting of American Society of Clinical Oncology (2025 ASC...

2025-06-03 11:00 2321

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer

SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2025-06-03 09:00 4146

2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors

SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-06-03 09:00 5933

Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025

BEIJING, June 2, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a promising self-developed TTVR system, and 1-year outcomes of JensC...

2025-06-03 09:00 2046

2025 ASCO |Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer

YANTAI, China, June 3, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beijing Cancer Hospital presented the results of a Phase 2 clinical study conducted in China evaluating the efficacy and safety of disitamab vedotin (DV...

2025-06-03 09:00 924

FiEE, Inc. Closes Its First Day of Trading on NASDAQ

Company resumed trading under its existing symbol "MINM"  HONG KONG, June 2, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:MINM) ("FiEE, Inc." or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, commenced the trading o...

2025-06-03 06:00 3871

Aon appoints Andy Marcell to serve as CEO of Global Solutions

DUBLIN, June 2, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, announced today that the firm has appointed Andy Marcell to serve as CEO of Global Solutions. As CEO of Global Solutions, Marcell now leads Aon's integrated Risk Capital and Human Capital capab...

2025-06-02 23:30 4362

WASHINGTON FREEDOM ANNOUNCES MULTI-YEAR PARTNERSHIP WITH CLOVER

Clover joins Washington Freedom as Official Partner and Kit Sponsor to elevate fan experience and expand cricket's reach in the U.S. WASHINGTON, June 2, 2025 /PRNewswire/ -- Washington Freedom, the first professional cricket franchise representing the nation's capital in Major League Cricket, p...

2025-06-02 23:12 4360

HOTEL101 PROGRESSES TOWARDS NASDAQ LISTING

U.S. SEC DECLARES FORM F-4 SEC REGISTRATION EFFECTIVE SINGAPORE, June 2, 2025 /PRNewswire/ -- Hotel101 Global Holdings Corp. ("Hotel101" or "HBNB") and JVSPAC Acquisition Corp. (NASDAQ: JVSA) ("JVSPAC") announced today that the United States Securities and Exchange Commission ("SEC") has declar...

2025-06-02 22:32 4501

NYSE Content Advisory: Pre-Market update + U.S. – China trade tensions escalate

NEW YORK, June 2, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Caroline Woods delivers the pre-market update on Jun 2nd * Stock...

2025-06-02 22:22 3800

Junee Limited Announces Completion of Corporate Name Change to SuperX AI Technology Limited and Commencement of Trading Under New Ticker Symbol "SUPX"

SINGAPORE, June 2, 2025 /PRNewswire/ -- NASDAQ-listed company Junee Limited (NASDAQ: JUNE) today announced that it has completed its previously announced corporate name change and re-branding to SuperX AI Technology Limited ("SuperX" or the "Company"). In connection with the name change, the Comp...

2025-06-02 21:47 5297

Health In Tech Chief Growth Officer to Be Featured on "New to The Street" Interview at NYSE

STUART, Fla., June 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to share that Chief Growth OfficerDustin Plantholt will be featured in an upcoming interview on "New to The Street," filmed live at the New York S...

2025-06-02 20:45 3662

Taoping Selected for New US$2.8 Million Agricultural Product Supply Contract; Company Continues to Build Momentum in Important Growth Market

SHENZHEN, China, June 2, 2025 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, today announced that it has been selected for a newRMB 20 million ( US$2.8 million) sales and purchase agreement. Under the latest agreeme...

2025-06-02 20:30 4436

XTEP Sponsors Vietnamese Top Runner Phạm Thị Hồng Lệ to Win VnExpress Marathon Ha Long 2025, Demonstrating Brand Strength and Professionalism

HA LONG, Vietnam, June 2, 2025 /PRNewswire/ -- Professional sportswear brand XTEP has sponsored top runner Phạm Thị Hồng Lệ in the VnExpress Marathon Ha Long 2025 on June 1, who won the competition with 02:59:31. The event, attracting thousands of elite runners, also saw XTEP-sponsored runners se...

2025-06-02 19:29 3048

Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil

New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON, June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, tod...

2025-06-02 15:00 2014

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

PETACH TIKVA, Israel, June 2, 2025 /PRNewswire/ -- ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical iso...

2025-06-02 09:00 3147

TuniTuni Opens New Storytelling Kids' Gym in Shek Mun, Hong Kong

HONG KONG, June 2, 2025 /PRNewswire/ -- TuniTuni, the beloved Korean kids' gym brand, is thrilled to announce the opening of its second Hong Kong center in Shek Mun on 1st June 2025. Located at Unit N, P. 19/F Kings Wing Plaza 2, No 1 On Kwan Street, Shatin, this new facility follows the phenomen...

2025-06-02 08:53 4314

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

SHANGHAI, June 1, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China (CT041-ST-01, NCT04581473) investigating satricabtagene au...

2025-06-02 08:15 2158

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer

SAN FRANCISCO, and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2025-06-02 08:00 4146

China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading

BEIJING, June 1, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), aChina-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that onMay 30, 2025, th...

2025-06-01 20:00 4298

Week's Top Stories